CI
ORGO icon

Cowen Inc’s Organogenesis Holdings ORGO Stock Holding History

Cowen Inc’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-107,724
Closed -$1.08K – 600
2018
Q2 		$1.08K Buy
+107,724
New +$1.08M 0.05% 205
2017
Q2 		– Sell
-58,160
Closed -$575K – 343
2017
Q1 		$575K Buy
+58,160
New +$575K 0.03% 162

Other funds holding ORGO

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
CFIC
City Financial Investment Company London, United Kingdom $562M AUM 5.93% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Cowen Inc's ORGO Position: Q3 2018 in Review

Cowen Inc sold out of Organogenesis Holdings (ORGO) in Q3 2018, closing a stake of 107,724 shares — an estimated $1.08K sold.

Cowen Inc first reported a position in ORGO in Q1 2017 and held it in 2 quarters. The position peaked at $575K in Q1 2017. 27 funds tracked by Wall St. Rank hold ORGO as of Q3 2018.

  • Cowen Inc reported no remaining Organogenesis Holdings position as of Q3 2018 after selling out during the quarter.
  • Cowen Inc sold 107,724 Organogenesis Holdings shares in Q3 2018, an estimated $1.08K.
  • Cowen Inc first reported a position in Organogenesis Holdings in Q1 2017 and held it in 2 quarters.
  • Cowen Inc's Organogenesis Holdings position peaked at $575K in Q1 2017.
  • 27 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2018.

Based on Cowen Inc's 13F filing for Q3 2018, filed 13 Nov 2018.